Biography
Biography: Kevin Spelman
Abstract
The term echinacea represents any number of species, but Echinacea purpurea and E. angustifolia make up the majority of species of echinacea in commerce. Given the in vitro, in vivo and clinical trial results, extractions from this botanically show an overall postive impact as an immunomodulator, namely in upper respiratory tract infections. Newer research hints at PPAR-g activity which may lend itself to utility in metabolic syndrome. In addition, some ergogenic has been done that is of interest. Past research will be reviewed, as well as some of the newer research on this popular botanical.